Skip to main content
. 2025 Oct 25;17(11):1384. doi: 10.3390/pharmaceutics17111384
IVM Ivermectin
COVID-19 Coronavirus disease of 2019
FDA United States Food and Drug Administration
WHO World Health Organization
NIH National Institutes of Health
GIT Gastrointestinal tract
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
ACE2 Angiotensin-converting enzyme 2
TMPRSS2 Transmembrane protease, serine 2
ROS Reactive oxygen species
3CLpro 3-Chymotrypsin-like Protease
HIF-1α Hypoxia-inducible factor 1-alpha
Vero/hSLAM cells Vero cells strongly expressing human signaling lymphocyte activation molecules
HDA Host-directed agent
RNA Ribonucleic acid
IMP Importin
HIV-1 Human immunodeficiency virus type 1
HAdV Human adenovirus
BoAHV-1 Varicellovirus bovinealpha 1
MDBK Madin-Darby Bovine Kidney
BT Bovine turbinate
STD Sexually transmitted disease
MIC Minimum inhibitory concentration
DNA Deoxyribonucleic acid
M. ulcerans Mycobacterium ulcerans
S. aureus Staphylococcus aureus
MRSA Methicillin-resistant Staphylococcus aureus
MSSA Methicillin-sensitive Staphylococcus aureus
CSCs Cancer stem-like cells
WNT Wingless signaling
TCF T-cell factor
mTOR Mammalian target of rapamycin
PAK1 p21-activated kinase 1
SID Surface-induced dissociation
MDR Multi-drug resistance
Bax Bcl-2 associated X protein
HIF Hypoxia-inducible factor
JNK c-Jun N-terminal kinase
ERK 1/2 Extracellular signal-regulated kinase 1 and 2
NO Nitric oxide
PGE2 Prostaglandin E2
NOS Nitric oxide synthase
COX2 Cyclooxygenase-2
TGF-β1 Transforming growth factor-beta 1
VEGF Vascular endothelial growth factor
FXR Farnesoid X receptor
LD50 Lethal dose 50%
w/w Weight per weight
ABCB1 ATP Binding Cassette Subfamily B Member 1
P-gp P-glycoprotein
ATP Adenosine triphosphate
CNS Central nervous system
ADME Absorption, distribution, metabolism, and excretion
SLNs Solid lipid nanoparticles
Hb Hemoglobin
TLC Total leucocyte count
DLC Differential leucocyte count
BUN Blood urea nitrogen
ALT Alanine transaminase
AST Aspartate transferase
Cmax Peak plasma concentration
t½ Elimination half-life
IV Intravenous
Tmax Duration/time to reach Cmax
SAHPRA South African Health Product Regulatory Authority
HPLC High-performance liquid chromatography
AUC Analytical peak area
ODT(s) Oral disintegrating tablet(s)
EC50 Half maximal effective concentration
ED Epidermis-dermis
SCE Stratum corneum-epidermis
CYP Cytochrome P
PNPs Polymeric nanoparticles
NLCs Nanostructured lipid carriers
SNEDDS Self-nano-emulsifying drug delivery systems
PLGA Poly(lactide-co-glycolide)
PEG Polyethylene glycol
GMP Good Manufacturing Practice
MSNs Mesoporous silica nanoparticles
IVM-MCM Ivermectin mesoporous silica particles
IVM-NC Ivermectin poly(ε-caprolactone) nanocapsules
PEDV Porcine epidemic diarrhea virus
C6 Coumarin 6
SEDDS Self-emulsifying drug delivery systems